Skip to Main Content

Author Details

Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
1993
442
55
PMIDPaper TitleJournal TitlePublished Year
37931286The impact of robotic surgery access on the management of patients with clinical stage I kidney tumors.Can Urol Assoc J2024
37558528Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools.Clin Genitourin Cancer2024
36253570PBRM1, SETD2 and BAP1 - the trinity of 3p in clear cell renal cell carcinoma.Nat Rev Urol2023
37992270Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care System.JCO Glob Oncol2023
37945903Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.Nat Genet2023
37494320Quantitative and qualitative impact of physician assistants in a Canadian urology setting.Can Urol Assoc J2023
37160325Association between the COVID-19 pandemic and first cancer treatment modality: a population-based cohort study.CMAJ Open2023
37126232Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance.J Urol2023
37156486Applying Quality Indicators to Examine Quality of Care During Active Surveillance in Low-Risk Prostate Cancer: A Population-Based Study.J Natl Compr Canc Netw2023
37421787Daily physical activity monitoring in older adults with metastatic prostate cancer on active treatment: Feasibility and associations with toxicity.J Geriatr Oncol2023
37419773Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement.Eur Urol2023
36948669Cystic Renal Masses: Old and New Paradigms.Urol Clin North Am2023
36988104Symptom experiences of older adults during treatment for metastatic prostate cancer: A qualitative investigation.J Geriatr Oncol2023
37211455Development, multi-institutional external validation, and algorithmic audit of an artificial intelligence-based Side-specific Extra-Prostatic Extension Risk Assessment tool (SEPERA) for patients undergoing radical prostatectomy: a retrospective cohort study.Lancet Digit Health2023
37409827Estimated glomerular filtration rate from the renal hypothermia trial: clinical implications.BJU Int2023
37439809Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial.Clin Cancer Res2023
37074425Predicting the recurrence risk of renal cell carcinoma after nephrectomy: potential role of CT-radiomics for adjuvant treatment decisions.Eur Radiol2023
37202328Comparison of patients with renal cell carcinoma in adjuvant therapy trials to a real-world population.Urol Oncol2023
36966064Surgeon-level versus hospital-level quality variance in kidney cancer surgery.Urol Oncol2023
36626169Timeliness and Modality of Treatment for New Cancer Diagnoses During the COVID-19 Pandemic in Canada.JAMA Netw Open2023
36475730Long-term Outcomes Following Active Surveillance of Low-grade Prostate Cancer: A Population-based Study Using a Landmark Approach.J Urol2023
36917921Feasibility and acceptability of remote symptom monitoring (RSM) in older adults during treatment for metastatic prostate cancer.J Geriatr Oncol2023
36746730A Matched Analysis of Active Surveillance Versus Nephrectomy for T1a Small Renal Masses.Eur Urol Oncol2023
36683418Low-volume grade group 2 prostate cancer candidates for active surveillance: a radical prostatectomy retrospective analysis.Scand J Urol2023
36710133Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer-A Report of a Movember International Consensus Meeting.Eur Urol Oncol2023
36639336Validating the total cancer location density metric for stratifying patients with low-risk localized prostate cancer at higher risk of grade group reclassification while on active surveillance.Urol Oncol2023
34324385Role of multiparametric MRI in long-term surveillance following focal laser ablation of prostate cancer.Br J Radiol2022
35676330Impact of cribriform pattern 4 and intraductal prostatic carcinoma on National Comprehensive Cancer Network (NCCN) and Cancer of Prostate Risk Assessment (CAPRA) patient stratification.Mod Pathol2022
35507051Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy.Eur Radiol2022
35735452Web-Based Peer Navigation for Men with Prostate Cancer and Their Family Caregivers: A Pilot Feasibility Study.Curr Oncol2022
35608445Impact of <sup>18</sup>F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer.Radiology2022
35537905Salvage partial gland ablation for recurrent prostate cancer following primary partial gland ablation: Functional and oncological outcomes.Urol Oncol2022
35534628Exploring the value of using patient-oriented MRI reports in clinical practice - a pilot study.Support Care Cancer2022
35852425Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men.Radiology2022
35754788Expansion of Lymphocytes from Prostatic Adenocarcinoma and Adjacent Nonmalignant Tissue.Prostate Cancer2022
35358414UPDATE - 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging.Can Urol Assoc J2022
35358410UPDATE - 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging - Summary of changes.Can Urol Assoc J2022
35686812A Comparison of Percutaneous Ablation Therapy to Partial Nephrectomy for cT1a Renal Cancers: Results from the Canadian Kidney Cancer Information System.J Urol2022
35622151Correction to: Exploring the value of using patientâ¿¿oriented MRI reports in clinical practice - a pilot study.Support Care Cancer2022
35621292Androgen deprivation therapy for prostate cancer: Prescribing behaviors and preferences among urologists.Can Urol Assoc J2022
37145553Reply by Authors.Urol Pract2022
37145537A Novel Metric for Hospital Quality in Kidney Cancer Surgery: A Veterans Affairs National Health System Validation of Concept.Urol Pract2022
36656705The rising burden of acute urological disease at an urban, academic hospital network.Can Urol Assoc J2022
36496458Single-cell profiling of healthy human kidney reveals features of sex-based transcriptional programs and tissue-specific immunity.Nat Commun2022
36031465Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer.Int J Radiat Oncol Biol Phys2022
36351330Incident Cancer Detection During Multiple Waves of COVID-19: The Tsunami After the Earthquake.J Natl Compr Canc Netw2022
363785722022 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).Can Urol Assoc J2022
36290888Cancer Patients First Treated with Chemotherapy: Are They More Likely to Receive Surgery in the Pandemic?Curr Oncol2022
35076300Effect of <sup>18</sup>F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial.Radiology2022
34862099A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis.Eur Urol2022
  • 1 - 50 of 442

Recommended Authors

Giovanni Motterle
Mayo Clinic
Career Start Year 2017
Number of shared co-authors 20
Jamil S Syed
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 3
Adam B Weiner
Northwestern University Feinberg School of Medicine
Career Start Year 2013
Number of shared co-authors 14
Neil Mendhiratta
National Cancer Institute, National Institutes of Health
Career Start Year 2013
Number of shared co-authors 3
David C Johnson
University of North Carolina School of Medicine
Career Start Year 2012
Number of shared co-authors 5
Devin N Patel
university of california san diego School of Medicine
Career Start Year 2011
Number of shared co-authors 3
Izak Faiena
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 3
Ridwan Alam
Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 20
Aaron A Laviana
Dell Medical School, The University of Texas at Austin
Career Start Year 2010
Number of shared co-authors 5
Joseph Brito
Yale School of Medicine
Career Start Year 2008
Number of shared co-authors 2
Michael A Liss
University of Texas Health San Antonio
Career Start Year 2008
Number of shared co-authors 12
Alastair D Lamb
University of Oxford
Career Start Year 2007
Number of shared co-authors 29
Adam Kinnaird
University of Alberta
Career Start Year 2007
Number of shared co-authors 12
Declan G Murphy
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2005
Number of shared co-authors 45
Amirali Salmasi
University of California San Diego
Career Start Year 2005
Number of shared co-authors 3
Chang Wook Jeong
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year 2005
Number of shared co-authors 0
Paul L Crispen
University of Florida
Career Start Year 2005
Number of shared co-authors 5
Jonathan L Wright
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 25
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 30
Tim Dudderidge
University Hospital Southampton NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 35
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2002
Number of shared co-authors 1
Karim Chamie
David Geffen School of Medicine at university of california los angeles
Career Start Year 2001
Number of shared co-authors 25
Ithaar H Derweesh
university of california san diego School of Medicine
Career Start Year 2000
Number of shared co-authors 8
Hyun Moo Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2000
Number of shared co-authors 1
Seong Il Seo
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1999
Number of shared co-authors 0
Jim C Hu
Weill Cornell Medical Center
Career Start Year 1998
Number of shared co-authors 21
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 6
Philip Cornford
Liverpool University Hospitals
Career Start Year 1988
Number of shared co-authors 14
Bruce J Trock
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 38
Hendrik Van Poppel
University Hospitals Leuven
Career Start Year 1981
Number of shared co-authors 29

Collaborators

Neil E Fleshner
University of Toronto
Co-authored papers 156
Girish S Kulkarni
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 87
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Co-authored papers 84
Andrew J Evans
Princess Margaret Cancer Center, University Health Network.
Co-authored papers 66
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 55
John Trachtenberg
University of Toronto, University Health Network
Co-authored papers 38
Ants Toi
Mount Sinai Hospital, University of Toronto
Co-authored papers 32
Masoom A Haider
University Health Network
Co-authored papers 28
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 17
Fred Saad
University of Montreal Health Center
Co-authored papers 16
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Co-authored papers 14
George Tomlinson
University Health Network
Co-authored papers 14
Martin E Gleave
University of British Columbia
Co-authored papers 11
Cynthia Kuk
Mount Sinai Hospital, University of Toronto, University Health Network
Co-authored papers 10
Katherine Lajkosz
Princess Margaret Hospital
Co-authored papers 10
Monique J Roobol
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 9
Joseph L Chin
University of Western Ontario
Co-authored papers 8
Janet L Stanford
Fred Hutchinson Cancer Research Center
Co-authored papers 7
Daniel W Lin
Co-authored papers 7
David Robert Siemens
Queen's University
Co-authored papers 7
Louis Lacombe
CHU de Quebec-Universite Laval
Co-authored papers 7
Armen Aprikian
McGill University Health Centre, McGill University
Co-authored papers 7
Kim N Chi
University of British Columbia
Co-authored papers 7
Todd M Morgan
University of Michigan ann arbor
Co-authored papers 7
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 7
Cezary Cybulski
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 6
Kathryn L Penney
Co-authored papers 6
Judith A Clements
Co-authored papers 6
Elio Riboli
Co-authored papers 6
Zsofia Kote-Jarai
The Institute of Cancer Research
Co-authored papers 6
Release 1.2